Stryker Corporation Share Price

Equities

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:01 13/05/2024 BST 5-day change 1st Jan Change
324.6 USD -1.82% Intraday chart for Stryker Corporation -0.29% +8.38%
Sales 2024 * 22.3B 1,776B Sales 2025 * 24B 1,910B Capitalization 126B 10,027B
Net income 2024 * 3.91B 311B Net income 2025 * 4.48B 357B EV / Sales 2024 * 5.97 x
Net Debt 2024 * 7.18B 571B Net Debt 2025 * 4.43B 353B EV / Sales 2025 * 5.43 x
P/E ratio 2024 *
31.9 x
P/E ratio 2025 *
27.8 x
Employees 52,000
Yield 2024 *
0.98%
Yield 2025 *
1.06%
Free-Float 94.61%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.82%
1 week-0.29%
Current month-3.55%
1 month-5.11%
3 months-4.48%
6 months+15.16%
Current year+8.38%
More quotes
1 week
323.51
Extreme 323.51
335.40
1 month
320.72
Extreme 320.715
346.33
Current year
292.43
Extreme 292.43
361.41
1 year
249.98
Extreme 249.98
361.41
3 years
188.84
Extreme 188.84
361.41
5 years
124.54
Extreme 124.54
361.41
10 years
77.87
Extreme 77.87
361.41
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 24/04/11
Director of Finance/CFO 62 31/12/02
Chief Tech/Sci/R&D Officer - 31/12/14
Members of the board TitleAgeSince
Director/Board Member 80 31/12/73
Director/Board Member 65 01/05/18
Director/Board Member 89 31/01/77
More insiders
Date Price Change Volume
13/05/24 324.6 -1.82% 1,540,974
10/05/24 330.6 -0.08% 1,307,926
09/05/24 330.9 +0.48% 980,439
08/05/24 329.3 -0.86% 1,214,050
07/05/24 332.1 +2.04% 1,331,236

Delayed Quote Nyse, May 13, 2024 at 09:00 pm

More quotes
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus